1)Schaap OL, Feltkamp TE, Breebaart AC:Circulating antibodies to corneal tissue in a patient suffering from Mooren's ulcer. Clin Exp Immunol 5:365-370, 1969
2)Brown SI, Mondino BJ, Rabin BS:Autoimmune phenomenon in Mooren's ulcer. Am J Ophthalmol 82:835-840, 1976
confocal scanning laser microscopy in the diagnosis and evaluation of treatment responses in Mooren's ulcer. Invest Ophthalmol Vis Sci 52:6680-6689, 2011
4)McAlister VC, Haddad E, Renouf E et al:Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation:a meta-analysis. Am J Transplant 6:1578-1585, 2006
5)Nakagawa H:Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis:review of randomized, double-blind clinical studies conducted in Japan. Clin Drug Investig 26:235-246, 2006
6)Martinez-Martinez S, Redondo JM:Inhibitors of the calcineurin/NFAT pathway. Curr Med Chem 11:997-1007, 2004
at a single-cell level. Immunol 75:136-142, 1992
8)Schwaninger M, Blume R, Oetjen E et al:The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. Naunyn Schmiedebergs Arch Pharmacol 348:541-545, 1993
9)Miyazaki D, Tominaga T, Kakimaru-Hasegawa A et al:Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 115:988-992, 2008
10)Soter NA, Fleischer AB Jr, Webster GF et al:Tacrolimus ointment for the treatment of atopic dermatitis in adult patients. J Am Acad Detmatol 44(suppl):S39-S46, 2001
11)本田まりこ:小児用タクロリムス軟膏の使い方.小児科 47:1125-1129,2006
12)小沢昌彦・市頭教克・梶原 淳・他:重症型春季カタルに対するタクロリムス軟膏の眼軟膏治療.あたらしい眼科 26:525-528,2009
13)Kinoshita S, Ohashi Y, Ohji M et al:Long-term results of keratoepithelioplasty in Mooren's ulcer. Ophthalmology 98:438-445, 1991